This is a StreetInsider.com Premium Only Page

C4 Therapeutics Inc. (CCCC) –

Apr 10, 2024 04:17 PM Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Mossler Mark

Apr 10, 2024 09:52 AM Form SC 13G C4 Therapeutics, Inc. Filed by: STATE STREET CORP

Apr 9, 2024 07:00 AM C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum

Apr 8, 2024 08:00 AM C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Associati

Apr 2, 2024 04:36 PM Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: Anderson Kenneth Carl

Apr 2, 2024 04:35 PM Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: Dubin Glenn

Apr 2, 2024 04:34 PM Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: GROGAN DONNA ROY

Mar 8, 2024 07:29 PM Form 4 C4 Therapeutics, Inc. For: Mar 07 Filed by: Boyle Scott N

Mar 8, 2024 07:26 PM Form 4 C4 Therapeutics, Inc. For: Mar 07 Filed by: Fisher Stewart

Mar 8, 2024 07:25 PM Form 4 C4 Therapeutics, Inc. For: Mar 07 Filed by: Schick Kelly

Mar 8, 2024 07:22 PM Form 4 C4 Therapeutics, Inc. For: Mar 07 Filed by: Adams Kendra

Mar 8, 2024 07:19 PM Form 4 C4 Therapeutics, Inc. For: Mar 07 Filed by: Siegel Jolie

Mar 8, 2024 04:11 PM Form 8-K C4 Therapeutics, Inc. For: Mar 08

Mar 8, 2024 01:12 PM Form SC 13G/A C4 Therapeutics, Inc. Filed by: WASATCH ADVISORS LP

Mar 5, 2024 04:30 PM C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024

Mar 4, 2024 12:37 PM C4 Therapeutics (CCCC) PT Raised to $14 at Jefferies

Mar 4, 2024 07:06 AM Form 8-K C4 Therapeutics, Inc. For: Mar 04

Mar 4, 2024 07:01 AM C4 Therapeutics (CCCC) Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins

Mar 4, 2024 07:00 AM C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins

Feb 27, 2024 12:05 PM C4 Therapeutics (CCCC) PT Lowered to $18 at UBS, 'well funded, multiple catalysts - one to watch in '24'

Feb 26, 2024 08:27 AM C4 Therapeutics (CCCC) PT Raised to $8 at Morgan Stanley

Feb 23, 2024 07:09 AM C4 Therapeutics (CCCC) PT Raised to $13 at Stifel

Feb 23, 2024 06:43 AM C4 Therapeutics (CCCC) PT Raised to $19 at BMO Capital

Feb 23, 2024 05:45 AM C4 Therapeutics (CCCC) PT Raised to $7 at Wells Fargo

Feb 22, 2024 09:02 AM Form S-8 C4 Therapeutics, Inc.

Feb 22, 2024 07:21 AM Form 10-K C4 Therapeutics, Inc. For: Dec 31

Feb 22, 2024 07:15 AM Form 8-K C4 Therapeutics, Inc. For: Feb 22

Feb 22, 2024 07:00 AM C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Feb 15, 2024 06:18 PM Form 4 C4 Therapeutics, Inc. For: Feb 15 Filed by: Hirsch Andrew

Feb 15, 2024 05:09 PM Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Hirsch Andrew

Feb 15, 2024 05:08 PM Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: REYNO LEONARD

Feb 15, 2024 05:07 PM Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Siegel Jolie

Feb 15, 2024 05:05 PM Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Fisher Stewart

Feb 15, 2024 05:05 PM Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Schick Kelly

Feb 15, 2024 05:03 PM Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N

Feb 15, 2024 05:03 PM Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Adams Kendra

Feb 14, 2024 10:05 AM Form SC 13G/A C4 Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Feb 14, 2024 09:21 AM Form SC 13G/A C4 Therapeutics, Inc. Filed by: Lynx1 Capital Management LP

Feb 14, 2024 07:36 AM Form SC 13G/A C4 Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP

Feb 9, 2024 01:04 PM Form SC 13G/A C4 Therapeutics, Inc. Filed by: WASATCH ADVISORS LP

Feb 5, 2024 10:24 AM Form SC 13G C4 Therapeutics, Inc. Filed by: Soleus Capital Master Fund, L.P.

Feb 2, 2024 09:34 AM Form SC 13G/A C4 Therapeutics, Inc. Filed by: Soleus Capital Master Fund, L.P.

Jan 29, 2024 04:27 AM JPMorgan Upgrades C4 Therapeutics (CCCC) to Neutral

Jan 12, 2024 04:02 PM Form SC 13G C4 Therapeutics, Inc. Filed by: Betta Investment (Hong Kong) Ltd.

Jan 11, 2024 07:06 AM Form 8-K C4 Therapeutics, Inc. For: Jan 11

Jan 9, 2024 04:06 PM Form 8-K C4 Therapeutics, Inc. For: Jan 09

Jan 9, 2024 04:01 PM C4 Therapeutics (CCCC) Announces 2024 Priorities and Extended Cash Runway

Jan 9, 2024 04:01 PM C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines

Jan 4, 2024 04:15 PM Form SC 13G C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Jan 4, 2024 04:01 PM C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals